Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection

Journal of Clinical Investigation

Volumn 116, Issue 12, 2006, Pages 3160-3170

  Popov, Alexey ^a   Abdullah, Zeinab ^a   Wickenhauser, Claudia ^a   Saric, Tomo ^a   Driesen, Julia ^a   Hanisch, Franz Georg ^a   Domann, Eugen ^b   Raven, Emma Lloyd ^c   Dehus, Oliver ^d   Hermann, Corinna ^d   Eggle, Daniela ^a   Debey, Svenja ^a   Chakraborty, Trinad ^b   Krönke, Martin ^a   Utermöhlen, Olaf ^a   Schultze, Joachim L ^a,e  

^a UNIVERSITY OF COLOGNE   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d UNIVERSITY OF KONSTANZ   (Germany)

^e UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INDOLEAMINE 2,3 DIOXYGENASE; INFLIXIMAB; ROFECOXIB;

ARTICLE; BARTONELLA HENSELAE; CELL COMPOSITION; CONTROLLED STUDY; DENDRITIC CELL; DOSE RESPONSE; DRUG ACTIVITY; GRANULOMA; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNITY; IN VITRO STUDY; IN VIVO STUDY; LISTERIA MONOCYTOGENES; LISTERIOSIS; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, CD; ANTIGENS, CD15; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELLS, CULTURED; CYCLOOXYGENASE 2; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GRANULOMA; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON TYPE II; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; MACROPHAGES; MEMBRANE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; S100 PROTEINS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33845304287     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI28996     Document Type: Article

References (78)

1. Kaufmann, S.H. 1993. Immunity to intracellular bacteria. Annu. Rev. Immunol. 11:129-163.
2. Gordon, S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3:23-35.
3. Pamer, E.G. 2004. Immune responses to Listeria monocytogenes. Nat. Rev. Immunol. 4:812-823.
4. Unanue, E.R. 1997. Studies in listeriosis show the strong symbiosis between the innate cellular system and the T-cell response. Immunol. Rev. 158:11-25.
5. Portnoy, D.A., Auerbuch, V., and Glomski, I.J. 2002. The cell biology of Listeria monocytogenes infection: the intersection of bacterial pathogenesis and cell-mediated immunity. J. Cell Biol. 158:409-414.
6. Drevets, D.A., et al. 2004. The Ly-6Chigh monocyte subpopulation transports Listeria monocytogenes into the brain during systemic infection of mice. J. Immunol. 172:4418-4424.
7. Torres, D., et al. 2004. Toll-like receptor 2 is required for optimal control of Listeria monocytogenes infection. Infect. Immun. 72:2131-2139.
8. Czuprynski, C.J., Henson, P.M., and Campbell, P.A. 1984. Killing of Listeria monocytogenes by inflammatory neutrophils and mononuclear phagocytes from immune and nonimmune mice. J. Leukoc. Biol. 35:193-208.
9. Cossart, P., and Sansonetti, P.J. 2004. Bacterial invasion: the paradigms of enteroinvasive pathogens. Science. 304:242-248.
10. Dussurget, O., Pizarro-Cerda, J., and Cossart, P. 2004. Molecular determinants of Listeria monocytogenes virulence. Annu. Rev. Microbiol. 58:587-610.
11. Lecuit, M., et al. 1999. A single amino acid in E-cadherin responsible for host specificity towards the human pathogen Listeria monocytogenes. EMBO J. 18:3956-3963.
12. Lecuit, M., et al. 2001. A transgenic model for listeriosis: role of internalin in crossing the intestinal barrier. Science. 292:1722-1725.
13. Southwick, F.S., and Purich, D.L. 1996. Intracellular pathogenesis of listeriosis. N. Engl. J. Med. 334:770-776.
14. Vazquez-Boland, J.A., et al. 2001. Listeria pathogenesis and molecular virulence determinants. Clin. Microbiol. Rev. 14:584-640.
15. Pron, B., et al. 2001. Dendritic cells are early cellular targets of Listeria monocytogenes after intestinal delivery and are involved in bacterial spread in the host. Cell. Microbiol. 3:331-340.
16. Edelson, B.T., and Unanue, E.R. 2000. Immunity to Listeria infection. Curr. Opin. Immunol. 12:425-431.
17. Feng, H., et al. 2005. Listeria-infected myeloid dendritic cells produce IFN-beta, priming T cell activation. J. Immunol. 175:421-432.
18. Muraille, E., et al. 2005. Distinct in vivo dendritic cell activation by live versus killed Listeria monocytogenes. Eur. J. Immunol. 35:1463-1471.
19. Harrington-Fowler, L., and Wilder, M.S. 1982. Fate of Listeria monocytogenes in murine peritoneal macrophage subpopulations. Infect. Immun. 35:124-132.
20. Gervais, F., Morris-Hooke, A., Tran, T.A., and Skamene, E. 1986. Analysis of macrophage bactericidal function in genetically resistant and susceptible mice by using the temperature-sensitive mutant of Listeria monocytogenes. Infect. Immun. 54:315-321.
21. Serbina, N.V., Salazar-Mather, T.P., Biron, C.A., Kuziel, W.A., and Pamer, E.G. 2003. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity. 19:59-70.
22. Kolb-Maurer, A., et al. 2000. Listeria monocytogenes-infected human dendritic cells: uptake and host cell response. Infect. Immun. 68:3680-3688.
23. Paschen, A., et al. 2000. Human dendritic cells infected by Listeria monocytogenes: induction of maturation, requirements for phagolysosomal escape and antigen presentation capacity. Eur. J. Immunol. 30:3447-3456.
24. Mielke, M.E., Peters, C., and Hahn, H. 1997. Cytokines in the induction and expression of T-cell-mediated granuloma formation and protection in the murine model of listeriosis. Immunol. Rev. 158:79-93.
25. Rogers, H.W., and Unanue, E.R. 1993. Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice. Infect. Immun. 61:5090-5096.
26. Conlan, J.W., and North, R.J. 1994. Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody. J. Exp. Med. 179:259-268.
27. Howie, A.J., Brown, G., Fisher, A.G., and Khan, M. 1984. Widespread distribution in human tissues of an antigenic determinant of granulocytes. J. Clin. Pathol. 37:555-559.
28. Lau, S.K., Chu, P.G., and Weiss, L.M. 2004. CD163: a specific marker of macrophages in paraffin-embedded tissue samples. Am. J. Clin. Pathol. 122:794-801.
29. Perez, L., et al. 2005. Comparative analysis of CD1a, S-100, CD83, and CD11c human dendritic cells in normal, premalignant, and malignant tissues. Histol. Histopathol. 20:1165-1172.
30. Mellor, A.L., and Munn, D.H. 2004. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4:762-774.
31. Kohrgruber, N., et al. 1999. Survival, maturation, and function of CD11c- and CD11c+ peripheral blood dendritic cells are differentially regulated by cytokines. J. Immunol. 163:3250-3259.
32. Sallusto, F., and Lanzavecchia, A. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1109-1118.
33. Von Bergwelt-Baildon, M.S., et al. 2006. CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition. Blood. 108:228-237.
34. McCaffrey, R.L., et al. 2004. A specific gene expression program triggered by Gram-positive bacteria in the cytosol. Proc. Natl. Acad. Sci. U. S. A. 101:11386-11391.
35. Tusher, V.G., Tibshirani, R., and Chu, G. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U. S. A. 98:5116-5121.
36. Tibshirani, R., Hastie, T., Narasimhan, B., and Chu, G. 2002. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc. Natl. Acad. Sci. U. S. A. 99:6567-6572.
37. Carlin, J.M., Borden, E.C., Sondel, P.M., and Byrne, G.I. 1989. Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes. J. Leukoc. Biol. 45:29-34.
38. Turco, J., and Winkler, H.H. 1986. Gamma-interferon-induced inhibition of the growth of Rickettsia prowazekii in fibroblasts cannot be explained by the degradation of tryptophan or other amino acids. Infect. Immun. 53:38-46.
39. Mackler, A.M., Barber, E.M., Takikawa, O., and Pollard, J.W. 2003. Indoleamine 2,3-dioxygenase is regulated by IFN-gamma in the mouse placenta during Listeria monocytogenes infection. J. Immunol. 170:823-830.
40. Braun, D., Longman, R.S., and Albert, M.L. 2005. A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation. Blood. 106:2375-2381.
41. Smith, W.L., DeWitt, D.L., and Garavito, R.M. 2000. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69:145-182.
42. Kabashima, K., et al. 2003. Prostaglandin E2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat. Med. 9:744-749.
43. Grell, M., et al. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell. 83:793-802.
44. Rose, F., et al. 2001. Human endothelial cell activation and mediator release in response to Listeria monocytogenes virulence factors. Infect. Immun. 69:897-905.
45. Leimeister-Wachter, M., Haffner, C., Domann, E., Goebel, W., and Chakraborty, T. 1990. Identification of a gene that positively regulates expression of listeriolysin, the major virulence factor of listeria monocytogenes. Proc. Natl. Acad. Sci. U. S. A. 87:8336-8340.
46. Fiedler, F. 1988. Biochemistry of the cell surface of Listeria strains: a locating general view. Infection. 16(Suppl. 2):S92-S97.
47. Cabeen, M.T., and Jacobs-Wagner, C. 2005. Bacterial cell shape. Nat. Rev. Microbiol. 3:601-610.
48. Takeuchi, O., et al. 1999. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity. 11:443-451.
49. Terness, P., et al. 2002. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J. Exp. Med. 196:447-457.
50. Tzianabos, A.O., and Kasper, D.L. 2002. Role of T cells in abscess formation. Curr. Opin. Microbiol. 5:92-96.
51. Tsunawaki, S., Sporn, M., Ding, A., and Nathan, C. 1988. Deactivation of macrophages by transforming growth factor-beta. Nature. 334:260-262.
52. Volkman, H.E., et al. 2004. Tuberculous granuloma formation is enhanced by a mycobacterium virulence determinant. PLoS Biol. 2:e367.
53. Lecuit, M., and Cossart, P. 2002. Genetically-modified-animal models for human infections: the Listeria paradigm. Trends Mol. Med. 8:537-542.
54. Grohmann, U., et al. 2001. IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase. J. Immunol. 167:708-714.
55. Munn, D.H., et al. 2002. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science. 297:1867-1870.
56. Terness, P., Chuang, J.J., and Opelz, G. 2006. The immunoregulatory role of IDO-producing human dendritic cells revisited. Trends Immunol. 27:68-73.
57. Kaufmann, S.H. 2002. Protection against tuberculosis: cytokines, T cells, and macrophages. Ann. Rheum. Dis. 61(Suppl. 2):ii54-ii58.
58. Zganiacz, A., et al. 2004. TNF-α is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. J. Clin. Invest. 113:401-413. doi:10.1172/JCI200418991.
59. Kindler, V., Sappino, A.P., Grau, G.E., Piguet, P.F., and Vassalli, P. 1989. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell. 56:731-740.
60. Flynn, J.L., et al. 1995. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity. 2:561-572.
61. Ehlers, S., et al. 2003. The lymphotoxin beta receptor is critically involved in controlling infections with the intracellular pathogens Mycobacterium tuberculosis and Listeria monocytogenes. J. Immunol. 170:5210-5218.
62. Keane, J., et al. 2001. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N. Engl. J. Med. 345:1098-1104.
63. Slifman, N.R., Gershon, S.K., Lee, J.H., Edwards, E.T., and Braun, M.M. 2003. Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents. Arthritis Rheum. 48:319-324.
64. Wallis, R.S., and Ehlers, S. 2005. Tumor necrosis factor and granuloma biology: explaining the differential infection risk of etanercept and infliximab. Semin. Arthritis Rheum. 34:34-38.
65. Furst, D.E., Wallis, R., Broder, M., and Beenhouwer, D.O. 2006. Tumor necrosis factor antagonists: different kinetics and/or mechanisms of action may explain differences in the risk for developing granulomatous infection. Semin. Arthritis Rheum. In press.
66. Wolf, A.M., et al. 2004. Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease. Clin. Immunol. 113:47-55.
67. Young, D.A., Lowe, L.D., and Clark, S.C. 1990. Comparison of the effects of IL-3, granulocyte-macrophage colony-stimulating factor, and macrophage colony-stimulating factor in supporting monocyte differentiation in culture. Analysis of macrophage antibody-dependent cellular cytotoxicity. J. Immunol. 145:607-615.
68. Akagawa, K.S., et al. 1996. Generation of CD1+RelB+ dendritic cells and tartrate-resistant acid phosphatase-positive osteoclast-like multinucleated giant cells from human monocytes. Blood. 88:4029-4039.
69. Utermohlen, O., Karow, U., Lohler, J., and Kronke, M. 2003. Severe impairment in early host defense against Listeria monocytogenes in mice deficient in acid sphingomyelinase. J. Immunol. 170:2621-2628.
70. Ouadrhiri, Y., Scorneaux, B., Sibille, Y., and Tulkens, P.M. 1999. Mechanism of the intracellular killing and modulation of antibiotic susceptibility of Listeria monocytogenes in THP-1 macrophages activated by gamma interferon. Antimicrob. Agents Chemother. 43:1242-1251.
71. Wadsworth, S.J., and Goldfine, H. 2002. Mobilization of protein kinase C in macrophages induced by Listeria monocytogenes affects its internalization and escape from the phagosome. Infect. Immun. 70:4650-4660.
72. Morath, S., Geyer, A., and Hartung, T. 2001. Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J. Exp. Med. 193:393-397.
73. Morath, S., Stadelmaier, A., Geyer, A., Schmidt, R.R., and Hartung, T. 2002. Synthetic lipoteichoic acid from Staphylococcus aureus is a potent stimulus of cytokine release. J. Exp. Med. 195:1635-1640.
74. Debey, S., et al. 2004. Comparison of different isolation techniques prior gene expression profiling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types. Pharmacogenomics. J. 4:193-207.
75. Chemnitz, J.M., et al. 2006. Prostaglandin E2 impairs CD4+ T cell activation by inhibition of lck: implications in Hodgkin's lymphoma. Cancer Res. 66:1114-1122.
76. Ihaka, R., and Gentleman, R.R. 1996. A language for data analysis and graphics. Journal of Computational and Graphical Statistics. 5:299-314.
77. Dietzsch, J., Gehlenborg, N., and Nieselt, K. 2006. Mayday-a microarray data analysis workbench. Bioinformatics. 22:1010-1012.
78. Saric, T., et al. 2001. Major histocompatibility complex class I-presented antigenic peptides are degraded in cytosolic extracts primarily by thimet oligopeptidase. J. Biol. Chem. 276:36474-36481.